{
  "catalogId": "11ae7813-c8b5-4a6f-a118-457fadea246c",
  "name": "COLUMVI",
  "status": "",
  "category": "29C",
  "registrationValidity": "valid",
  "registrationNumber": "176 69 37772 00",
  "treatmentDescriptions": "Columvi is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including DLBCL arising from indolent lymphoma, and high-grade B cell lymphoma after two or more lines of systemic therapy.",
  "termsOfIssue": "",
  "form": "concentrate for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "GLOFITAMAB/",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01FX28",
      "name": "GLOFITAMAB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת ",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "COLUMVI 1MG/ML VIAL 2.5ML",
      "manufacturer": {
        "name": NaN,
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 2.5,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "30",
      "storageConditions": "",
      "codes": {
        "moh": "21017",
        "barcode": "7290014774278"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": NaN,
        "retailMargin": NaN,
        "maxRetailPrice": NaN,
        "maxPriceWithVAT": NaN
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T14:10:20.110646"
  }
}